Russia Moves To Free Foreign Drugs From Repeated Clinical Trials
This article was originally published in PharmAsia News
Executive Summary
Russia’s Federal Antimonopoly Service said it is considering law changes that would free foreign drugs that already have undergone suitable clinical trials from having to go through new trials in Russia.
You may also be interested in...
Horizon Teprotumumab's US Advisory Cmte. Likely To Focus On Labeling, Not Approval, Questions
FDA seems poised to approve the drug for the orphan eye disease called TED, but remains concerned about labeling for some adverse events.
Introducing The Citeline Awards 2020; Nominations Open
The 2020 Citeline Awards, Informa’s premier event recognizing excellence in R&D, recognize the myriad achievements across the industry and are open for nominations through 17 January.
US FDA Puts Spotlight On Alkermes' Violative Vivitrol Ad
The apparently first-ever FDA press release for an advertising warning letter underscores importance of opioid issues – and the agency’s changing approach to media relations in general. FDA objects to Alkermes journal ad that excludes risk information about its opioid dependence treatment drug.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports